project id: TCGA-THCA; case submitter id: TCGA-ET-A2N4; source center: 23; state: released; a260 a280 ratio: 1.77; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 3.1; rna integrity number: 8.0; age at index: 53; days to birth: -19671; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1955; age at diagnosis: 19671; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 81.0; icd 10 code: C73; last known disease status: not reported; morphology: 8340/3; primary diagnosis: Papillary carcinoma, follicular variant; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Thyroid gland; synchronous malignancy: No; tissue or organ of origin: Thyroid gland; tumor grade: Not Reported; year of diagnosis: 2008; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1218; days to sample procurement: 0; initial weight: 220.0; portion submitter id: TCGA-ET-A2N4-01A-12; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 95.0;